HomePage
What's New
Physicians
About Us
Heart Disease
Procedures
Office Services
Location
Links
Index
Testimonials
Research

Should you have any questions contact our office via e-mail or call

713-529-5530

James Michael Wilson, M. D.

Hall-Garcia Cardiology Associates
affiliated with the

Texas Heart Institute

Research and Publications

  1. Wilson JM, George WG, et al. "Toxicity of Dioxins"  Open File No. 20. Environmental Institute for Waste Management  Studies - Publications, University of Alabama 191pp. 1988
  2. Wilson MJ, Ferguson JJ: The therapeutic potential of abcirximab  (c7E3 Fab) in percutaneous transluminal coronary angioplasty:  Implications of the EPIC study. Clin Immunother 1994; 1(1):1-7
  3. Barasch E, Wilson JM, Ferguson JJ: Anticoagulation and PTCA.  Developments in Cardiology 1994; 4(7):91-104.
  4. Ferguson JJ, Wilson JM: Coronary Artery Bypass Surgery and  Percutaneous Transluminal Coronary Angioplasty. In Willerson  JT, Cohn JN: Cardiovascular Medicine, Churchill Livingstone,  New York 1995:670-701.
  5. Wilson JM, Dougherty KG, Ellis KO, Ferguson JJ: Activated  clotting times in acute coronary syndromes and percutaneous coronary  angioplasty. Cathet Cardiov Diag 1995; 34:1-5.
  6. Ferguson JJ, Wilson JM: Early and late ischemic complications  of PTCA. J Inv Cardiol 1994; 6 (Suppl A):3A-12A.
  7. Khoshnevis R, Wilson JM, Ferguson JJ: Non-invasive imaging  of the cardiovascular system: Electron beam computed tomography  and magnetic resonance imaging. Current Opinion in Cardiology  1994, 9:729-739.
  8. Wilson JM, Silberman H, Ferguson JJ: Abrupt vascular closure.  Journal of Invasive Cardiology 1994; 6:306-313.
  9. Ferguson JJ, Barasch E, Wilson JM, et al.: The relation of  clinical outcome to dissection and thrombus formation during  coronary angioplasty. J Inv Cardiol 1995; 7:2-10.
  10. Wilson JM, Ferguson JJ: Revascularization therapy for coronary  artery disease. Coronary artery bypass grafting versus percutaneous  transluminal coronary angioplasty. Tex Heart Inst J 1995; 22:145-161.
  11. Ferguson JJ, Dohmen P, Wilson JM, Vaughn WK, Khoshnevis R,  Kmonicek P, McKinney AA, Plachetka JR: Results of a national  survey on anticoagulation for PTCA. J Invas Cardiol 1995; 7:136-141.
  12. Ferguson JJ, Waly HM, Wilson JM: Mechanism and role of platelets  in ischemic events: action of therapeutic agents. J Inv Card  1996, 8 (Suppl B):1B-7B.
  13. Barasch E, Conger JL, Peters JJ, Nesdahl K, Fenimore JG,  Wilson JM, Ferguson JJ: PTCA in angulated segments: Effects of  balloon material, balloon length, and inflation sequence on straightening  forces in an in-vitro model. Cathe Cardiov Diagn 1996; 39:207-212.
  14. Wilson JM, Kalife G, Rogers M, Strickman N, Massumi AM: An  unusual electrocardiographic presentation of right ventricular  infarction. THI Journal 1996;4:305-9.
  15. Ferguson JJ, Wilson JM: Future directions for PTCA: Anticoagulation  monitoring and new antithrombotic agents. J Inv Cardiol (in press)
  16. Ferguson JJ, Wilson JM: Coronary artery bypass surgery and  PTCA: Impact on morbidity and mortality in patients with CAD.  THI Journal (in press)
  17. Strickman N, Wilson JM: Peripheral vascular disease. In: Cardiovascular Disease in Women. Eds: Wilansky SW, Willerson  JT. In Press.

 

Manuscripts Submitted for Publication
 

  1. Wilson M, Angelini P, Dear W, Leatherman L, Ferguson JJ:  Laser Balloon Angioplasty: The THI Experience.
  2. Barasch E, Conger JL, Peters JJ, Nesdahl K, Fenimore JG,  Wilson JM, Ferguson JJ: PTCA of lesions on a bend: Effects of  balloon material, balloon length, and inflation sequence on straightening  forces on an in-vitro model.
  3. Wilson JM, Yaryura R, Harlan M, Ferguson JJ, Benrey J. Treatment  of In-Stent Restenosis

 

Abstracts
 

  1. Barasch E, Wilson JM, Ferguson JJ, and the MARCATOR Investigators:  Do vessel size and balloon/artery ratio influence restenosis  after PTCA? J Am Coll Cardiol February 1994:70A.
  2. Barasch E, Conger JL, Janota T, Peters JJ, Nesdahl K, Fenimore  JG, Vaughn WK, Wilson JM, Ferguson JJ: PTCA of lesions on a bend:  Effects of balloon material, balloon length, and inflation sequence.  Circulation 1994; 90:I-435.
  3. Wilson JM, Capek P, McAllister HA, Vaughn WK, Ferguson JJ,  Clubb FJ Jr., Buja LM, Willerson JT: Coronary lesion histology  in stable, unstable and evolving angina pectoris. J Am Coll Cardiol  February 1995:279A-280A.
  4. Yaryura R, Wilson JM, Angelini P, Fish RD, Ferguson JJ: High  risk coronary stenting with Reopro. Submitted to AHA

 


Ongoing Research
 

  1. Use of the ACT to guide heparin administration.
  2. The use of pulmonary artery input impedence in the evaluation  of secondary pulmonary hypertension.
  3. Echocardiographic indices of contractile function in patients  considered for ventricular reduction surgery.
  4. The use of a modified velocity of circumferential fiber shortening  and end systolic wall stress to detect subclinical ventricular  dysfunction in patients with severe mitral regurgitation.

 © 1998, 2000, 2002, 2003, 2004, 2005, 2006, 2007, 2008  by Hall-Garcia  Cardiology Associates - Last revised May15, 2008

Please contact our WebMaster with any questions or comments